Le Lézard
Classified in: Health
Subjects: PDT, PSF

Catalytic Health is Launching a New Magazine for the Life Sciences Industry


TORONTO, May 2, 2024 /CNW/ - Hypothesis, an important new magazine for the life sciences industry, is now available online and in print. Catalytic Health, Canada's largest independent medical publisher, is launching the thrice-yearly publication to both inspire and inform people who work in the pharmaceutical, medical device, and biotech fields in Canada.

With news, features, and interviews with patients, physicians, researchers and industry movers and shakers, Hypothesis offers a breadth of voices on relevant and timely industry topics. These include challenges to accessing medications in Canada, advocacy, marketing strategies, and new product news. Hypothesis will also include big picture perspectives on how technologies like AI and breakthroughs in gene editing, obesity treatment, and more are shaping the industry.

"Through Hypothesis, Catalytic Health is proud to be able to spotlight the impressive growth and exciting innovation in Canada's life sciences industry, while sharing news, strategies, and inspirational stories," explains Rohit Khanna, president and managing director of Catalytic Health.

To register for digital and/or print issues for Hypothesis, please visit: hypothesismag.com.

About Catalytic Health

One of Canada's leading medical communications firms, Catalytic Health is the country's largest independent medical publisher, one of Canada's largest scientific conference providers, and a leader in innovative events and services for the life sciences industry.

SOURCE Catalytic Health


These press releases may also interest you

at 06:18
The Week in Canadian Press Releases: 10 Stories You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
The Future is Now: Companion Diagnostics Market to Surge to $15.4 Billion by 2028
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 05:00
WellSync Powers The Vitamin Shoppe's New Whole Health Rx Telehealth Service
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...

at 04:00
Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...

More news about Health...


News published on and distributed by: